Department of Pediatrics, University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.
University of Minnesota Division of Biostatistics, Minneapolis, MN, USA.
Clin Endocrinol (Oxf). 2018 Jun;88(6):813-819. doi: 10.1111/cen.13580. Epub 2018 Mar 24.
Children with congenital adrenal hyperplasia (CAH) are exposed to fluctuating cortisol and androgen levels. The effects these hormonal states have on bone mineral density (BMD) and body composition are not well studied. The study's objective was to compare BMD and body composition, including visceral adipose tissue (VAT) and Android:Gynoid (A:G) ratio, in children with CAH vs healthy age-matched, sex-matched and BMI-matched controls.
Total body BMD (TBMD) Z-scores were adjusted for height-for-age Z-scores (TBMDHAZ). Hydrocortisone dose (mg/m2/d) was averaged over the past year. Bone age Z-scores were used as a surrogate for long-term androgen exposure in cases. Statistical analyses comparing cases and controls accounted for matched groups using mixed linear models.
Forty-two cases with CAH (average age 12.3 years [SE 3]; 17 males) and 101 controls underwent a dual-energy X-ray absorptiometry scan.
Children with CAH had lower TBMD (0.81 vs 1.27, P = .003) and TBMD Z-scores (-0.51 vs -0.01, P = .001) than controls. In CAH cases, TBMD and TBMD Z-scores were positively correlated with bone age Z-scores (r = .63, P < .0001; r = .51, P = .001, respectively) but were not associated with HC dose. VAT and the A:G ratio did not differ significantly between children with CAH and controls and neither was associated with HC dose.VAT was not associated with bone age Z-score.
Lower BMD was observed in CAH cases compared with controls although no differences in body composition were identified. Among CAH cases, increased chronic androgen exposure, as measured by bone age Z-scores, was associated with higher BMD but was not associated with VAT.
患有先天性肾上腺皮质增生症(CAH)的儿童会出现皮质醇和雄激素水平波动。这些激素状态对骨密度(BMD)和身体成分的影响尚未得到充分研究。本研究的目的是比较 CAH 患儿与年龄、性别和 BMI 匹配的健康对照组的 BMD 及身体成分,包括内脏脂肪组织(VAT)和安卓:女性(A:G)比值。
全身骨密度(TBMD)Z 评分通过身高年龄 Z 评分(TBMDHAZ)进行调整。过去一年的平均氢化可的松剂量(mg/m2/d)。在病例中,骨龄 Z 评分被用作长期雄激素暴露的替代指标。使用混合线性模型,通过匹配组比较病例和对照组的统计分析。
42 例 CAH 患儿(平均年龄 12.3 岁[SE 3];17 名男性)和 101 名对照组接受双能 X 线吸收法扫描。
CAH 患儿的 TBMD(0.81 对 1.27,P=0.003)和 TBMD Z 评分(-0.51 对-0.01,P=0.001)均低于对照组。在 CAH 病例中,TBMD 和 TBMD Z 评分与骨龄 Z 评分呈正相关(r=0.63,P<0.0001;r=0.51,P=0.001),但与 HC 剂量无关。CAH 患儿与对照组的 VAT 和 A:G 比值无显著差异,与 HC 剂量也无显著相关。VAT 与骨龄 Z 评分无关。
与对照组相比,CAH 患儿的 BMD 较低,但身体成分无差异。在 CAH 病例中,骨龄 Z 评分所反映的慢性雄激素暴露增加与 BMD 升高相关,但与 VAT 无关。